New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 19, 2014
10:42 EDTMNKD, JCP, YPF, AMPE, PLUG, KING, VHC, NWBO, ACHN, ARWROptions with decreasing implied volatility
Options with decreasing implied volatility: ARWR VHC AMPE ACHN KING YPF NWBO PLUG JCP MNKD
News For ARWR;VHC;AMPE;ACHN;KING;YPF;NWBO;PLUG;JCP;MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 26, 2014
10:12 EDTARWROptions with decreasing implied volatility
Options with decreasing implied volatility: VNET GME ARWR GMCR SGMS DSW DANG ARUN JMEI MBLY
06:07 EDTACHNStocks with implied volatility above IV index mean; DG ACHN
Subscribe for More Information
November 24, 2014
13:32 EDTJCPJ.C. Penney director discloses 100K share purchase at $7.28
J.C. Penney director Javier Teruel disclosed in a filing late Friday the purchase of 100K shares at $7.28 on Nov. 19. Shares of JCP are up 5.5% in early afternoon trading.
November 21, 2014
05:52 EDTMNKDStocks with implied volatility movement; MNKD LOCO
Subscribe for More Information
05:39 EDTMNKDMannKind, Sanofi on track to launch Afrezza in Q1, says Piper Jaffray
Subscribe for More Information
November 20, 2014
11:49 EDTVHCVirnetX updates licensing declarations to ETSI, ATIS
Subscribe for More Information
10:29 EDTYPFYPF initiated with a Buy at Deutsche Bank (pre-open)
Subscribe for More Information
06:59 EDTKINGKing Digital new Candy Crush game off to 'great' start, says Deutsche Bank
Deutsche Bank says King Digital's newly launched Candy Crush Soda Saga hit the top downloaded app and top 5 grossing app in the U.S. faster than any King game in history. Deutsche says it is incrementally more positive on the stock and upped its price target for shares to $16 from $13. It keeps a Hold rating on the name.
06:41 EDTPLUGPlug Power implied volatility of 73 at lower end of index mean range
Subscribe for More Information
November 19, 2014
15:23 EDTNWBONorthwest Biotherapeutics announces $35M in financing actions
Subscribe for More Information
10:25 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
07:30 EDTKINGMorgan Stanley to hold a conference
European Technology, Media & Telecoms Conference is being held in Barcelona, Spain on November 19-21.
07:11 EDTAMPESociety for Free Radical Biology and Medicine to hold annual meeting
Subscribe for More Information
05:44 EDTACHNStocks with implied volatility movement; MCD KO
Subscribe for More Information
November 18, 2014
10:20 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
09:20 EDTPLUGOn The Fly: Pre-market Movers
Subscribe for More Information
09:14 EDTPLUGPlug Power share rise after client installs GenFuel hydrogen infrastructure
Subscribe for More Information
07:32 EDTARWRArrowhead files for regulatory permission to begin Phase I ARC-AAT trial
Arrowhead Research recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate, ARC-AAT, for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. Pending approval, Arrowhead intends to proceed with a double blind, placebo-controlled dose escalation, Phase 1 study to determine the safety, tolerability, pharmacokinetics and effect on circulating alpha-1 antitrypsin levels of ARC-AAT in healthy volunteers and patients with alpha-1 antitrypsin deficiency. The study is planned to start in Australia in healthy volunteers and will dose escalate until predetermined levels of alpha-1 antitrypsin reduction are reached. Once these levels of protein knockdown are achieved, the study will transition into a population of patients with ZZ genotype alpha-1 antitrypsin deficiency to further evaluate escalating doses of ARC-AAT. The study is designed to enroll up to 48 subjects, including healthy volunteers and alpha-1 antitrypsin deficiency patients. The application was submitted to an ethics committee in compliance with the Clinical Trial Notification process of the Australian Department of Health and Ageing, Therapeutic Goods Administration.
November 17, 2014
14:21 EDTJCPEarnings Preview: Home Depot shares up over 17% since last earnings report
Subscribe for More Information
12:03 EDTJCPOptions with decreasing implied volatility
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use